Treatment of relapsed Hodgkin's disease

Bailliere's Clinical Haematology

Volumn 9, Issue 3, 1996, Pages 559-572

  Gause, B L ^a   Longo, D L ^a  

^a Frederick Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CAMPTOTHECIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; TAXANE DERIVATIVE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CLINICAL TRIAL; DRUG MEGADOSE; HODGKIN DISEASE; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; REMISSION; REVIEW; TREATMENT FAILURE;

EID: 0029829596     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80027-8     Document Type: Article

References (62)

1. Anderson JE Litzow MR Appelbaum FR Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience Journal of Clinical Oncology 11 1993 2342 2350
2. Bensinger WI Weaver CH Appelbaum FR Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 85 1995 1655 1658
3. Bierman PJ Bagin RG Jagannath S High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long term follow-up in 128 patients Annals of Oncology 4 1993 767 773
4. Bierman PJ Vose JM Leichner PK Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease Journal of Clinical Oncology 11 1993 698 703
5. Bonadonna G Zucali R Monfardini S Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP Cancer 36 1975 252 259
6. Canellos GP Anderson JR Propert KJ Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD New England Journal of Medicine 327 1992 1478 1484
7. Carella AM Congiu AM Gaozza E High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian Study Group report Journal of Clinical Oncology 6 1988 1411 1416
8. Carella AM Carlier P Congiu A Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol Bone Marrow Transplantation 8 1991 99 103
9. Chao NJ Schriber JR Grimes K Granulocyte colony-stimulating factor ‘mobilized’ peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy Blood 81 1993 2031 2035
10. Chopra R McMillan AK Linch DC The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients Blood 81 1993 1137 1145
11. Connors JM Klimo P MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease Seminars in Hematology 24 1987 35 40 supplement 1
12. DeVita VT Jr Simon RM Hubbard SM Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute Annals of Internal Medicine 92 1980 587 595
13. Devizzi L Santoro A Bonfante V Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease Annals of Oncology 5 1994 817 820
14. Dunlop DJ Fitzsimons EJ McMurray A Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue British Journal of Cancer 70 1994 943 945
15. (abstract no. 987) Fabian C Dahlberg S Miller T Efficacy of low dose involved field (LDIF) XRT in producing and maintaining CR following PR induction with MOP-BAP chemotherapy in Hodgkin's disease, results of Southwest Oncology Group Study Proceedings of the American Society of Clinical Oncology 8 1989 253
16. Ferme C Bastion Y Lepage E The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease Annals of Oncology 6 1995 543 549
17. Fisher RI DeVita VT Hubbard SP Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse Annals of Internal Medicine 90 1979 761 771
18. Gianni AM Siena S Bregni M Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation Lancet ii 1989 580 585
19. Gianni AM Siena S Bregni M Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease Annals of Oncology 2 1991 645 653
20. Gisselbrecht C Maraninchi D Pico JL Interleukin-2 treatment in lymphoma: a phase II multicenter study Blood 83 1994 2081 2085
21. Gribben JG Linch DC Singer CRJ Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation Blood 73 1989 340 344
22. Gulati SC Bennett CL Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease Annals of Internal Medicine 116 1992 177 182
23. Hagemeister FB Tannir N McLaughlin P MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease Journal of Clinical Oncology 5 1987 556 561
24. Harker WG Kushlan P Rosenberg SA Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe Annals of Internal Medicine 101 1984 440 446
25. Hoppe RT Coleman CN Cox RS The management of stage I–II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience Blood 59 1982 455 456
26. Jagannath S Dicke KA Armitage JO High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease Annals of Internal Medicine 104 1986 163 168
27. Jagannath S Armitage JO Dicke KA Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease Journal of Clinical Oncology 7 1989 179 185
28. Katsanis E Weisdorf DJ Xu Z Infusions of interleukin-1 alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with anti-lymphoma cytolytic activity Journal of Clinical Immunology 14 1994 205 211
29. Kessinger A Bierman PJ Vose JM Armitage JO High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease Blood 77 1991 2322 2325
30. Khwaja A Linch DC Goldstone AH Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial British Journal of Haematology 82 1992 317 323
31. Lenhard RE Jr Order SE Spunberg JJ Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease Journal of Clinical Oncology 3 1985 1296 1300
32. Linch DC Winfield D Goldstone AH Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial Lancet 341 1993 1051 1054
33. Lohri A Connors JM Identification of risk factors in patients treated for first relapse of Hodgkin's disease Leukemia and Lymphoma 15 1994 189 200
34. Lohri A Barnett M Fairey DE Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970–1988 Blood 77 1991 2292 2298
35. Longo DL Young RC Wesley M Twenty years of MOPP therapy for Hodgkin's disease Journal of Clinical Oncology 4 1986 1295 1306
36. Longo DL Duffey PL Young RC Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure Journal of Clinical Oncology 10 1992 210 218
37. Mazza P Tura S Bocchia M Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective European Journal of Haematology 52 1990 22 24
38. Nemunaitis J Rabinowe SN Singer JW Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer New England Journal of Medicine 324 1991 1773 1778
39. Nemunaitis J Rosenfeld C Collins R Allogeneic transplantation combining mobilized blood and bone marrow in patients with refractory hematologic malignancies Transfusion 35 1995 666 673
40. O'Brien PC Parnis FX Salvage radiotherapy following chemotherapy failure in Hodgkin's disease—what is its role? Acta Oncologica 34 1995 99 104
41. Petersen IA Kapp DS Local hyperthermia and radiation therapy in the retreatment of superficially located recurrences in Hodgkin's disease International Journal of Radiation Oncology Biology Physics 18 1990 603 611
42. Pfreundschuh MG Schoppe WD Fuchs R Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group Cancer Treatment Reports 71 1987 1203 1207
43. Pfreundschuh MG Rueffer U Lathan B Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group Journal of Clinical Oncology 12 1994 580 586
44. Phillips GL Wolff SN Herzig RH Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation Blood 73 1989 2086 2092
45. Reece DE Phillips GL Intensive therapy and autotransplantation in Hodgkin's disease Stem Cells 12 1994 477 493
46. Reece DE Barnett MJ Connors JM Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease Journal of Clinical Oncology 9 1991 1871 1879
47. Roach M III Kapp DS Rosenberg SA Hoppe RT Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease Journal of Clinical Oncology 5 1987 550 555
48. Rybak ME McCarroll K Bernard S Interferon therapy of relapsed and refractory Hodgkin's disease: cancer and leukemia group B study 8652 Journal of Biological Reponse Modifiers 9 1990 1 4
49. Santoro A Bonfante V Bonadonna G Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease Annals of Internal Medicine 96 1982 139 143
50. Santoro A Viviani S Valagussa P CCNU etoposide and prednimustine (CEP) in refractory Hodgkin's disease Seminars in Oncology 13 1986 23 26 supplement 1
51. Sheridan WP Begley CG Juttner CA Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy Lancet 339 1992 640 644
52. Stahel RA Jost LM Cerny T Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies Journal of Clinical Oncology 12 1994 1931 1938
53. Tannir N Hagemeister F Velasquez W Long term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease Journal of Clinical Oncology 1 1983 432 439
54. Taylor KM Jagannath S Spitzer G Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease Journal of Clinical Oncology 7 1989 1791 1799
55. Tepler I Schwartz G Parker K Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy Cancer 73 1994 1276 1285
56. Urba WJ Longo DL Hodgkin's disease New England Journal of Medicine 326 1992 678 687
57. Viviani S Santoro A Negretti V Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission Annals of Oncology 1 1990 123 127
58. Vose JM Bierman PH Anderson JR Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up Blood 80 1992 2142 2148
59. (abstract) Weisdorf D Daniels K Miller W Bone marrow vs peripheral blood stem cells for autologous lymphoma transplantation: a prospective randomized trial Blood 82 supplement 1 1993 444
60. Wheeler C Antin JH Churchill WH Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study Journal of Clinical Oncology 8 1990 648 656
61. Yahalom J Gulati SC Toia M Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease Journal of Clinical Oncology 11 1993 1062 1070
62. Zinzani PL Barbieri E Gherlinzoni F Radiotherapy in early stage Hodgkin's disease Leukemia and Lymphoma 13 1994 285 289